Literature DB >> 10186958

Abbreviated aerosol therapy for improved efficiency.

J W Mason1, W C Miller.   

Abstract

BACKGROUND: The Circulaire nebulizer system (WestMed, Tucson, AZ) has been shown to minimize the potential for side effects from adrenergic bronchodilator aerosols by minimizing extrapulmonary deposition. This study evaluates the utility, safety, and efficacy of a shortened treatment protocol utilizing a timed treatment with concentrated drug in this device.
METHODS: Prospective, randomized, controlled comparison was conducted of a 2-minute treatment of concentrated (5 mg/mL) albuterol in the Circulaire nebulizer versus a conventional unit dose treatment as assessed by pulmonary function testing.
RESULTS: Both treatments were equally efficacious and safe. The abbreviated treatment consumed about 8 to 10 minutes less and was preferred by patients.
CONCLUSIONS: Abbreviated treatments provide equal bronchodilation with improved efficiency and potential cost savings.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10186958     DOI: 10.1089/jam.1998.11.127

Source DB:  PubMed          Journal:  J Aerosol Med        ISSN: 0894-2684


  1 in total

1.  Dose-response to salbutamol via a novel palm sized nebuliser (Aerodose Inhaler), conventional nebuliser (Pari LC Plus) and metered dose inhaler (Ventolin Evohaler) in moderate to severe asthmatics.

Authors:  Brian J Lipworth; Erika J Sims; Karla Taylor; Wendy Cockburn; Robert Fishman
Journal:  Br J Clin Pharmacol       Date:  2005-01       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.